# A Long Term Safety Extension Study (CHS-0214-05)

> **NCT02486939** · PHASE3 · COMPLETED · sponsor: **Coherus Oncology, Inc.** · enrollment: 359 (actual)

## Conditions studied

- Rheumatoid Arthritis
- Plaque Psoriasis

## Interventions

- **DRUG:** CHS-0214

## Key facts

- **NCT ID:** NCT02486939
- **Lead sponsor:** Coherus Oncology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2017-09
- **Final completion:** 2017-10
- **Target enrollment:** 359 (ACTUAL)
- **Last updated:** 2018-12-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02486939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02486939, "A Long Term Safety Extension Study (CHS-0214-05)". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT02486939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*